Expression Pattern of the Hippo Pathway Effector TAZ in Cellular and Fibrotic Nonspecific Interstitial Pneumonia

Expression Pattern of the Hippo Pathway Effector TAZ in Cellular and Fibrotic Nonspecific Interstitial Pneumonia

Bibliographic Details
Main Authors:	Min-Kyung Yeo, Hee Sun Park, Yeon Hee Park, Choong-Sik Lee, Geon Yoo, Dong Il Park, Jeong Eun Lee, Jae Young Moon, Sung Soo Jung, Ju Ock Kim, Dahyun Kang, Hyun Jin Cho, Min-Woong Kang, Jin-Whan Kim, Song-Soo Kim, Chaeuk Chung
Format:	Article
Language:	English
Published:	Wolters Kluwer 2018-01-01
Series:	Chinese Medical Journal
Online Access:	http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=5;spage=626;epage=628;aulast=Yeo

Similar Items

Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis
by: Wen-Hsuan Yang, et al.
Published: (2020-01-01)

High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
by: Hyuk Moon, et al.
Published: (2019-01-01)

The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
by: Wen-Hsuan Yang, et al.
Published: (2019-09-01)

The effector of Hippo signaling, Taz, is required for formation of the micropyle and fertilization in zebrafish.
by: Xiaogui Yi, et al.
Published: (2019-01-01)

Clinical characteristics and prognostic factors of fibrotic nonspecific interstitial pneumonia
by: Hyun Kyu Cho, et al.
Published: (2022-04-01)

Hippo-YAP/TAZ pathway regulation: the crucial roles of lncRNAs in cancer
by: Wonyi Jang, et al.
Published: (2023-12-01)

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
by: Hwang, Jun-Ha, et al.
Published: (2022)

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
by: Hwang, Jun-Ha, et al.
Published: (2021)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
by: Reza Bayat Mokhtari, et al.
Published: (2023-07-01)

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
by: Antonio Cigliano, et al.
Published: (2022-06-01)

Modeling the Control of TGF-β/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap
by: Bita Labibi, et al.
Published: (2020-08-01)

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse HepatocarcinogenesisSummary
by: Haichuan Wang, et al.
Published: (2021-01-01)

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
by: Maribel Escoll, et al.
Published: (2020-02-01)

Transcriptional Co-repressor Function of the Hippo Pathway Transducers YAP and TAZ
by: Minchul Kim, et al.
Published: (2015-04-01)

Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer
by: Sahar Sarmasti Emami, et al.
Published: (2024-04-01)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
by: Oleg Dobrokhotov, et al.
Published: (2018-08-01)

The Hippo Pathway Effectors YAP/TAZ Are Essential for Mineralized Tissue Homeostasis in the Alveolar Bone/Periodontal Complex
by: Mirali Pandya, et al.
Published: (2022-03-01)

Radiation-Induced Fibrotic Tumor Microenvironment Regulates Anti-Tumor Immune Response
by: Jae-Kyung Nam, et al.
Published: (2021-10-01)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
by: Gandhi T. K. Boopathy, et al.
Published: (2019-04-01)

The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
by: Ryan E. Hillmer, et al.
Published: (2019-05-01)

The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
by: Emanuel Rognoni, et al.
Published: (2019-05-01)

Roles of Hippo–YAP/TAZ signalling in intervertebral disc degeneration
by: Shi Zheng-wei, et al.
Published: (2023-03-01)

HGF and IL-10 expressing ALB::GFP reporter cells generated from iPSCs show robust anti-fibrotic property in acute fibrotic liver model
by: Ja Sung Choi, et al.
Published: (2020-08-01)

Early detection of delayed pneumothorax using lung ultrasound after transthoracic needle lung biopsy: A prospective pilot study
by: Jeong Suk Koh, et al.
Published: (2022-05-01)

Factors affecting treatment outcome in patients with idiopathic nonspecific interstitial pneumonia: a nationwide cohort study
by: Sang Hoon Lee, et al.
Published: (2017-12-01)

Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer
by: Seong-Hun Kim, et al.
Published: (2019-09-01)

Impact of nonspecific allograft biopsy findings in symptomatic kidney transplant recipients
by: Bon Jin Koo, et al.
Published: (2024-02-01)

Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
by: Da Hyun Kang, et al.
Published: (2020-06-01)

New Insights into Hippo/YAP Signaling in Fibrotic Diseases
by: Masum M. Mia, et al.
Published: (2022-06-01)

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
by: Dongyi Liu, et al.
Published: (2023-04-01)

Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
by: Tianai Sun, et al.
Published: (2021-05-01)

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing
by: Chao Tang, et al.
Published: (2023-02-01)

Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
by: Tae Hun Kim, et al.
Published: (2023-02-01)

YAP/TAZ initiate and maintain Schwann cell myelination
by: Matthew Grove, et al.
Published: (2017-01-01)

A study of the effectiveness of using the serum procalcitonin level as a predictive test for bacteremia in acute pyelonephritis
by: Ga Hee Lee, et al.
Published: (2018-12-01)

TAZ stimulates exercise‐induced muscle satellite cell activation via Pard3–p38 MAPK–TAZ signalling axis
by: Kyung Min Kim, et al.
Published: (2023-12-01)

Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
by: Ji Eun Shin, et al.
Published: (2023-11-01)

Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease
by: Mathias Cobbaut, et al.
Published: (2020-01-01)

The Hippo–YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury
by: Feihong Deng, et al.
Published: (2022-07-01)

The Hippo Signaling Core Components YAP and TAZ as New Prognostic Factors in Lung Cancer
by: Yu Jiang, et al.
Published: (2022-03-01)